Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$190.90 USD
+0.18 (0.09%)
Updated Oct 13, 2025 03:59 PM ET
After-Market: $190.70 -0.20 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Johnson & Johnson has a market cap of $459.32B, which represents its share price of $190.72 multiplied by its outstanding shares number of 2.41B. As a large-cap company, JNJ's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
JNJ 190.90 +0.18(0.09%)
Will JNJ be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for JNJ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JNJ
Markets Rebound Nicely Ahead of Q3 Earnings Season
Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is J&J's MedTech Segment Set for Another Quarter of Growth?
3 Defensive Stocks to Watch as Trade Tensions Resurface: GILD, JNJ, KR
Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know
Other News for JNJ
Protagonist Therapeutics falls amid a report J&J deal price may be lower
Johnson & Johnson (JNJ) Q3 Earnings Preview: MedTech Focused Performance
Johnson & Johnson Q3 Preview: With Stock Near All-Time Highs, Here's What To Watch
Johnson & Johnson Stock (JNJ) Falters Ahead of Earnings Release as Cancer Therapy Gets Warning Label
Johnson & Johnson Stock (JNJ) Falters Ahead of Earnings as Cancer Therapy Gets Warning Label